Table 5.
Construction of logistic model
| Variable | β | S.E | Wald | P | OR | 95% CI | |
|---|---|---|---|---|---|---|---|
| Lower | Upper | ||||||
| Intercept | − 2.551 | 0.925 | 7.600 | 0.006 | |||
| Age | − 0.015 | 0.013 | 1.245 | 0.265 | 0.985 | 0.961 | 1.011 |
| Gender | |||||||
| Male | Ref | ||||||
| Female | 0.063 | 0.253 | 0.062 | 0.803 | 1.065 | 0.649 | 1.749 |
| Acute exacerbation in previous 1 year | |||||||
| No | Ref | ||||||
| Yes | 1.351 | 0.254 | 28.364 | < 0.001 | 3.863 | 2.349 | 6.351 |
| LABA | |||||||
| No | Ref | ||||||
| Yes | 1.715 | 0.643 | 7.121 | 0.008 | 5.556 | 1.577 | 19.577 |
| ICS | |||||||
| No | Ref | ||||||
| Yes | − 1.398 | 0.664 | 4.433 | 0.035 | 0.247 | 0.067 | 0.908 |
| ALT | − 0.010 | 0.009 | 1.462 | 0.227 | 0.990 | 0.973 | 1.006 |
| CAT Score | 0.105 | 0.026 | 16.177 | < 0.001 | 1.110 | 1.055 | 1.168 |
LABA long-acting β agonist, ICS inhaled corticosteroids, ALT glutamic-pyruvic transaminase, CAT COPD assessment test